99 related articles for article (PubMed ID: 21531601)
1. Clotrimazole disrupts glycolysis in human breast cancer without affecting non-tumoral tissues.
Coelho RG; Calaça Ide C; Celestrini Dde M; Correia AH; Costa MA; Sola-Penna M
Mol Genet Metab; 2011 Aug; 103(4):394-8. PubMed ID: 21531601
[TBL] [Abstract][Full Text] [Related]
2. Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes.
Meira DD; Marinho-Carvalho MM; Teixeira CA; Veiga VF; Da Poian AT; Holandino C; de Freitas MS; Sola-Penna M
Mol Genet Metab; 2005 Apr; 84(4):354-62. PubMed ID: 15781197
[TBL] [Abstract][Full Text] [Related]
3. Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells.
Motawi TM; Sadik NA; Fahim SA; Shouman SA
Chem Biol Interact; 2015 May; 233():147-56. PubMed ID: 25863232
[TBL] [Abstract][Full Text] [Related]
4. Clotrimazole inhibits and modulates heterologous association of the key glycolytic enzyme 6-phosphofructo-1-kinase.
Zancan P; Rosas AO; Marcondes MC; Marinho-Carvalho MM; Sola-Penna M
Biochem Pharmacol; 2007 May; 73(10):1520-7. PubMed ID: 17291460
[TBL] [Abstract][Full Text] [Related]
5. Clotrimazole potentiates the inhibitory effects of ATP on the key glycolytic enzyme 6-phosphofructo-1-kinase.
Marcondes MC; Sola-Penna M; Zancan P
Arch Biochem Biophys; 2010 May; 497(1-2):62-7. PubMed ID: 20346906
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase.
Gomez LS; Zancan P; Marcondes MC; Ramos-Santos L; Meyer-Fernandes JR; Sola-Penna M; Da Silva D
Biochimie; 2013 Jun; 95(6):1336-43. PubMed ID: 23454376
[TBL] [Abstract][Full Text] [Related]
7. Lactate favours the dissociation of skeletal muscle 6-phosphofructo-1-kinase tetramers down-regulating the enzyme and muscle glycolysis.
Costa Leite T; Da Silva D; Guimarães Coelho R; Zancan P; Sola-Penna M
Biochem J; 2007 Nov; 408(1):123-30. PubMed ID: 17666012
[TBL] [Abstract][Full Text] [Related]
8. Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity.
Spitz GA; Furtado CM; Sola-Penna M; Zancan P
Biochem Pharmacol; 2009 Jan; 77(1):46-53. PubMed ID: 18851958
[TBL] [Abstract][Full Text] [Related]
9. Filamentous actin and its associated binding proteins are the stimulatory site for 6-phosphofructo-1-kinase association within the membrane of human erythrocytes.
Real-Hohn A; Zancan P; Da Silva D; Martins ER; Salgado LT; Mermelstein CS; Gomes AM; Sola-Penna M
Biochimie; 2010 May; 92(5):538-44. PubMed ID: 20144679
[TBL] [Abstract][Full Text] [Related]
10. Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an over-expressed but strongly product-inhibited hexokinase.
Marín-Hernández A; Rodríguez-Enríquez S; Vital-González PA; Flores-Rodríguez FL; Macías-Silva M; Sosa-Garrocho M; Moreno-Sánchez R
FEBS J; 2006 May; 273(9):1975-88. PubMed ID: 16640561
[TBL] [Abstract][Full Text] [Related]
11. Serotonin stimulates mouse skeletal muscle 6-phosphofructo-1-kinase through tyrosine-phosphorylation of the enzyme altering its intracellular localization.
Coelho WS; Costa KC; Sola-Penna M
Mol Genet Metab; 2007 Dec; 92(4):364-70. PubMed ID: 17720578
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex type 1 activates glycolysis through engagement of the enzyme 6-phosphofructo-1-kinase (PFK-1).
Abrantes JL; Alves CM; Costa J; Almeida FC; Sola-Penna M; Fontes CF; Souza TM
Biochim Biophys Acta; 2012 Aug; 1822(8):1198-206. PubMed ID: 22542512
[TBL] [Abstract][Full Text] [Related]
13. Nanomicellar Formulation of Clotrimazole Improves Its Antitumor Action toward Human Breast Cancer Cells.
Marcondes MC; Fernandes AC; Itabaiana I; de Souza RO; Sola-Penna M; Zancan P
PLoS One; 2015; 10(6):e0130555. PubMed ID: 26098874
[TBL] [Abstract][Full Text] [Related]
14. Muscle-type 6-phosphofructo-1-kinase and aldolase associate conferring catalytic advantages for both enzymes.
Marcondes MC; Sola-Penna M; Torres Rda S; Zancan P
IUBMB Life; 2011 Jun; 63(6):435-45. PubMed ID: 21698747
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells.
Zancan P; Sola-Penna M; Furtado CM; Da Silva D
Mol Genet Metab; 2010 Aug; 100(4):372-8. PubMed ID: 20483646
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol-3-kinase as a putative target for anticancer action of clotrimazole.
Furtado CM; Marcondes MC; Carvalho RS; Sola-Penna M; Zancan P
Int J Biochem Cell Biol; 2015 May; 62():132-41. PubMed ID: 25794423
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.
Yalcin A; Telang S; Clem B; Chesney J
Exp Mol Pathol; 2009 Jun; 86(3):174-9. PubMed ID: 19454274
[TBL] [Abstract][Full Text] [Related]
18. Effects of Ca(2+)-ionophore A23187 and calmodulin antagonists on regulatory mechanisms of glycolysis and cell viability of NIH-3T3 fibroblasts.
Ashkenazy-Shahar M; Beitner R
Mol Genet Metab; 1999 Aug; 67(4):334-42. PubMed ID: 10444344
[TBL] [Abstract][Full Text] [Related]
19. Binding of phosphofructokinase to filamentous actin.
Roberts SJ; Somero GN
Biochemistry; 1987 Jun; 26(12):3437-42. PubMed ID: 2958082
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory effect of fatty acid treatment on glucose utilization in human erythrocytes.
Duan YJ; Murase S; Okuda J; Tamura A; Miwa I
Biochim Biophys Acta; 1997 Feb; 1334(1):89-97. PubMed ID: 9042369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
